Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Sanford Stem Cell Institute Innovation Center and Stem Cell Program, University of California San Diego, La Jolla, CA, USA.
Nat Biotechnol. 2024 Sep;42(9):1429-1441. doi: 10.1038/s41587-023-02014-0. Epub 2024 Jan 2.
RNA-binding proteins (RBPs) modulate alternative splicing outcomes to determine isoform expression and cellular survival. To identify RBPs that directly drive alternative exon inclusion, we developed tethered function luciferase-based splicing reporters that provide rapid, scalable and robust readouts of exon inclusion changes and used these to evaluate 718 human RBPs. We performed enhanced cross-linking immunoprecipitation, RNA sequencing and affinity purification-mass spectrometry to investigate a subset of candidates with no prior association with splicing. Integrative analysis of these assays indicates surprising roles for TRNAU1AP, SCAF8 and RTCA in the modulation of hundreds of endogenous splicing events. We also leveraged our tethering assays and top candidates to identify potent and compact exon inclusion activation domains for splicing modulation applications. Using these identified domains, we engineered programmable fusion proteins that outperform current artificial splicing factors at manipulating inclusion of reporter and endogenous exons. This tethering approach characterizes the ability of RBPs to induce exon inclusion and yields new molecular parts for programmable splicing control.
RNA 结合蛋白 (RBPs) 通过调节可变剪接的结果来决定异构体的表达和细胞的存活。为了鉴定直接驱动可变外显子包含的 RBP,我们开发了基于连接功能的荧光素酶剪接报告基因,可快速、可扩展且稳健地检测外显子包含变化,并使用这些报告基因来评估 718 个人类 RBP。我们进行了增强交联免疫沉淀、RNA 测序和亲和纯化质谱分析,以研究一组先前与剪接无关联的候选物。这些分析的综合分析表明,TRNAU1AP、SCAF8 和 RTCA 在调节数百个内源性剪接事件方面具有惊人的作用。我们还利用我们的连接测定和顶级候选物来鉴定用于剪接调节应用的强效和紧凑的外显子包含激活结构域。使用这些鉴定的结构域,我们设计了可编程融合蛋白,这些蛋白在操纵报告基因和内源性外显子的包含方面优于当前的人工剪接因子。这种连接方法可表征 RBPs 诱导外显子包含的能力,并为可编程剪接控制提供新的分子部件。